Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug access
Pharma
Teva, Samsung Bioepis deepen biosimilar bonds with new deal
Already sharing the load on two biosimilar assets, Teva Pharmaceutical and Samsung Bioepis have elected to take their partnership to the next level.
Fraiser Kansteiner
Oct 2, 2026 10:00am
Lilly to expand global GLP-1 access by 2040
Sep 28, 2026 9:59am
Newly uncovered MFN drug pricing details reignite concerns
Sep 21, 2026 12:02am
NICE rebuffs Gilead's twice-yearly PrEP option
Sep 10, 2026 10:12am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
Colorado wins FDA approval to import cheaper drugs from Canada
Jun 17, 2026 10:30am
